Supplementary Table S4 from Immunotherapy with a HER2-Targeting <i>Listeria</i> Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma

Abstract

&lt;p&gt;Signalment and primary tumor characteristics of dogs in the historical control group.&lt;/p&gt;